NCT01758354View on ClinicalTrials.gov

Newborn Screening Assay of Pompe's Disease

NACompletedINTERVENTIONAL

Enrollment

236,536

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions

Pompe Disease

Interventions

OTHER

Pompe disease newborn screening

DBS will be tested for acid alpha-glucosidase (GAA)activity. Newborns with low GAA activity will received a confirmatory blood sampling and clinical evaluation for the presence of cardiomyopathy.

Trial Locations (1)

Unknown

National Taiwan University Hospital, Taipei

All Listed Sponsors

lead

National Taiwan University Hospital

OTHER

NCT01758354 - Newborn Screening Assay of Pompe's Disease | Biotech Hunter | Biotech Hunter